Savara Inc. (SVRA)
NASDAQ
Market Cap
$530.65M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
48 of 809
Rank in Industry
40 of 445
Largest Insider Buys in Sector
SVRA Stock Price History Chart
SVRA Stock Performance
About Savara Inc.
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
Insider Activity of Savara Inc.
Over the last 12 months, insiders at Savara Inc. have bought $10.02M and sold $885,323 worth of Savara Inc. stock.
On average, over the past 5 years, insiders at Savara Inc. have bought $2.61M and sold $481,596 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SANDELL SCOTT D (10 percent owner) — $26M. BASKETT FOREST (10 percent owner) — $23M. Florence Anthony A. Jr. (10 percent owner) — $17M.
The last purchase of 333,333 shares for transaction amount of $999,999 was made by Yang Rick (10 percent owner) on 2023‑07‑17.
List of Insider Buy and Sell Transactions, Savara Inc.
| 2023-12-28 | Sale | Pauls Matthew | CHIEF EXECUTIVE OFFICER | 84,000 0.0609% | $4.71 | $395,900 | -1.46% | |
| 2023-12-28 | Sale | Lowrance David L | CHIEF FINANCIAL OFFICER | 10,000 0.0072% | $4.71 | $47,131 | -1.46% | |
| 2023-12-28 | Sale | Elam Nevan C | director | 93,843 0.068% | $4.71 | $442,291 | -1.46% | |
| 2023-07-17 | Yang Rick | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | Walker Paul Edward | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | SANDELL SCOTT D | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | Mathers Edward T | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | Makhzoumi Mohamad | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | Growth Equity Opportunities 17, LLC | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | Florence Anthony A. Jr. | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | Chang Carmen | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | Behbahani Ali | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-07-17 | BASKETT FOREST | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
| 2023-06-26 | Pratt Raymond Dennis | Chief Medical Officer | 6,500 0.0047% | $2.93 | $19,045 | +53.21% | ||
| 2023-05-26 | RAMSAY DAVID A | director | 37,124 0.024% | $2.63 | $97,599 | +44.36% | ||
| 2023-05-25 | RAMSAY DAVID A | director | 12,876 0.0084% | $2.57 | $33,130 | +48.84% | ||
| 2023-05-24 | RAMSAY DAVID A | director | 50,000 0.0322% | $2.56 | $127,800 | +47.69% | ||
| 2022-12-30 | RAMSAY DAVID A | director | 29,000 0.0189% | $1.55 | $44,834 | +101.94% | ||
| 2022-12-29 | RAMSAY DAVID A | director | 7,000 0.0046% | $1.54 | $10,752 | +104.58% | ||
| 2022-12-28 | RAMSAY DAVID A | director | 3,293 0.0021% | $1.50 | $4,923 | +107.67% |
Insider Historical Profitability
33.07%
| Yang Rick | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Chang Carmen | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Behbahani Ali | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| BASKETT FOREST | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| SANDELL SCOTT D | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Mathers Edward T | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Makhzoumi Mohamad | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Walker Paul Edward | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Florence Anthony A. Jr. | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Growth Equity Opportunities 17, LLC | 10 percent owner | 24471264 18.0812% | $3.84 | 1 | 0 | |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER | 1302674 0.9625% | $3.84 | 10 | 1 | <0.0001% |
| Lowrance David L | CHIEF FINANCIAL OFFICER | 342355 0.253% | $3.84 | 3 | 11 | +23.24% |
| Pratt Raymond Dennis | Chief Medical Officer | 160000 0.1182% | $3.84 | 2 | 0 | +110.62% |
| Elam Nevan C | director | 22500 0.0166% | $3.84 | 0 | 1 | |
| LEVINE EVAN | CEO & President | 4395000 3.2474% | $3.84 | 13 | 7 | |
| RAMSAY DAVID A | director | 2201142 1.6264% | $3.84 | 51 | 0 | +40.1% |
| EMANUELE ROBERT MARTIN | Senior VP, Development | 547663 0.4047% | $3.84 | 0 | 1 | |
| Neville Robert N | Chief Executive Officer | 498028 0.368% | $3.84 | 2 | 4 | +85.25% |
| Chowdhury Badrul A. | CHIEF MEDICAL OFFICER | 175000 0.1293% | $3.84 | 1 | 1 | +24.29% |
| McCracken Joseph S | director | 168337 0.1244% | $3.84 | 2 | 0 | +29.35% |
| Jouhikainen Jaakko Taneli | President and COO | 167569 0.1238% | $3.84 | 1 | 7 | +85.25% |
| PIKOVER YURI | director | 153734 0.1136% | $3.84 | 3 | 0 | +39.18% |
| Roberts Brandi | Chief Financial Officer & SVP | 38000 0.0281% | $3.84 | 2 | 0 | <0.0001% |
| MERRITT JAMES A | President & Chf Med Officer | 35000 0.0259% | $3.84 | 1 | 0 | |
| Culley Brian M | CEO and Director | 34500 0.0255% | $3.84 | 3 | 1 | +7.08% |
| ROBBINS JOAN M | CSO, Sr. VP | 10000 0.0074% | $3.84 | 2 | 2 | |
| PYKETT MARK JEROME | director | 8000 0.0059% | $3.84 | 1 | 0 | |
| Hawkins Richard J | director | 0 0% | $3.84 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Nea Management Company Llc | $121.87M | 17.71 | 24.47M | 0% | +$0 | 1.4 | |
| Bain Capital Life Sciences Investors Llc | $72.54M | 10.54 | 14.57M | +2.34% | +$1.66M | 7.29 | |
| Tcg Crossover Management Llc | $49.8M | 7.24 | 10M | 0% | +$0 | 0.08 | |
| JENNISON ASSOCIATES LLC | $44.03M | 6.4 | 8.84M | +0.3% | +$132,532.73 | 0.03 | |
| Adage Capital Partners Gp L L C | $41.27M | 6 | 8.29M | +8.51% | +$3.24M | 0.08 | |
| BlackRock | $36.06M | 5.24 | 7.24M | -0.27% | -$98,180.70 | <0.01 | |
| The Vanguard Group | $30.2M | 4.39 | 6.06M | +2.51% | +$740,391.53 | <0.01 | |
| Frazier Life Sciences Management L P | $19.92M | 2.9 | 4M | 0% | +$0 | 1.02 | |
| Wellington Management Company | $13.84M | 2.01 | 2.78M | +34.9% | +$3.58M | <0.01 | |
| Janus Henderson | $12.75M | 1.86 | 2.56M | +41.07% | +$3.71M | 0.01 | |
| Farallon Capital | $11.92M | 1.73 | 2.39M | -61.72% | -$19.23M | 0.08 | |
| Geode Capital Management | $11.79M | 1.71 | 2.37M | +1.76% | +$203,867.36 | <0.01 | |
| Sofinnova | $11.69M | 1.7 | 2.35M | -1.49% | -$177,158.52 | 0.02 | |
| Vivo Capital | $10.4M | 1.51 | 2.09M | 0% | +$0 | 0.92 | |
| State Street | $9.36M | 1.36 | 1.88M | +6.33% | +$557,814.80 | <0.0001 | |
| Nantahala Capital Management Llc | $8.65M | 1.26 | 1.74M | +75.87% | +$3.73M | 0.89 | |
| GHOST TREE CAPITAL LLC | $7.97M | 1.16 | 1.6M | +113.33% | +$4.23M | 2.59 | |
| Altium Capital Management Lp | $6.65M | 0.97 | 1.33M | +0.15% | +$9,960.00 | 3.09 | |
| AXA | $6.63M | 0.96 | 1.33M | -23.87% | -$2.08M | 0.02 | |
| Affinity Asset Advisors | $5.73M | 0.83 | 1.15M | 0% | +$0 | 1.02 | |
| Prudential Financial | $5.67M | 0.82 | 1.14M | +16.95% | +$821,201.98 | 0.01 | |
| ExodusPoint Capital Management, LP | $5.41M | 0.79 | 1.09M | New | +$5.41M | 0.07 | |
| Walleye Capital | $5.11M | 0.74 | 1.03M | +1,053.59% | +$4.67M | 0.01 | |
| Opaleye Management Inc | $4.26M | 0.62 | 855,000 | New | +$4.26M | 0.67 | |
| Northern Trust | $4M | 0.58 | 803,159 | +1.04% | +$41,085.00 | <0.01 | |
| Deutsche Bank | $3.75M | 0.55 | 753,885 | +2,173.13% | +$3.59M | <0.01 | |
| Two Sigma | $2.8M | 0.41 | 562,186 | +313.85% | +$2.12M | 0.01 | |
| Two Sigma Advisers LP | $2.49M | 0.36 | 499,115 | +1,278.2% | +$2.31M | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $1.96M | 0.28 | 392,723 | +46.29% | +$618,894.63 | 0.01 | |
| BNY Mellon | $1.28M | 0.19 | 256,183 | -13.36% | -$196,799.43 | <0.0001 | |
| ClariVest Asset Management LLC | $1.24M | 0.18 | 249,309 | +0.19% | +$2,325.66 | 0.13 | |
| Charles Schwab | $1.21M | 0.18 | 242,575 | -2.41% | -$29,815.27 | <0.0001 | |
| Morgan Stanley | $1.15M | 0.17 | 231,564 | +4.54% | +$50,068.98 | <0.0001 | |
| Algert Global LLC | $983,000.00 | 0.14 | 197,430 | New | +$983,000.00 | 0.04 | |
| Schonfeld Group | $881,958.00 | 0.13 | 177,100 | +759.71% | +$779,370.00 | 0.01 | |
| Bank of America | $842,741.00 | 0.12 | 169,225 | +111% | +$443,339.78 | <0.0001 | |
| JPMorgan Chase | $831,621.00 | 0.12 | 166,992 | +93.41% | +$401,632.43 | <0.0001 | |
| Nuveen | $807,816.00 | 0.12 | 162,212 | 0% | +$0 | <0.0001 | |
| Swiss National Bank | $732,060.00 | 0.11 | 147,000 | New | +$732,060.00 | <0.01 | |
| Goldman Sachs | $721,502.00 | 0.11 | 144,880 | +13.9% | +$88,046.35 | <0.0001 | |
| Dimensional Fund Advisors | $688,290.00 | 0.1 | 138,211 | -4.86% | -$35,178.68 | <0.0001 | |
| RhumbLine Advisers | $666,957.00 | 0.1 | 133,929 | +2.97% | +$19,247.43 | <0.01 | |
| Qube Research & Technologies | $602,286.00 | 0.09 | 120,941 | -3.82% | -$23,943.83 | <0.01 | |
| Options Solutions Llc | $551,132.00 | 0.08 | 110,669 | New | +$551,132.00 | 0.32 | |
| UBS | $541,261.00 | 0.08 | 108,687 | +2.31% | +$12,205.97 | <0.0001 | |
| Awm Investment Company Inc | $498,000.00 | 0.07 | 100,000 | New | +$498,000.00 | 0.07 | |
| Alps Advisors Inc | $475,401.00 | 0.07 | 95,462 | +5% | +$22,624.15 | <0.01 | |
| Credit Suisse | $451,711.00 | 0.07 | 90,705 | New | +$451,711.00 | <0.0001 | |
| Susquehanna International Group | $440,969.00 | 0.06 | 88,548 | +170.78% | +$278,118.03 | <0.0001 | |
| Ubs Oconnor Llc | $435,436.00 | 0.06 | 87,437 | -50.57% | -$445,455.75 | 0.04 |